NovoCure Ltd Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NovoCure Ltd quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • NovoCure Ltd Operating Income (Loss) for the quarter ending September 30, 2024 was -$32.1M, a 44.9% increase year-over-year.
  • NovoCure Ltd Operating Income (Loss) for the twelve months ending September 30, 2024 was -$159M, a 29.1% increase year-over-year.
  • NovoCure Ltd annual Operating Income (Loss) for 2023 was -$233M, a 160% decline from 2022.
  • NovoCure Ltd annual Operating Income (Loss) for 2022 was -$89.5M, a 102% decline from 2021.
  • NovoCure Ltd annual Operating Income (Loss) for 2021 was -$44.3M, a 246% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$233M -$143M -160% Jan 1, 2023 Dec 31, 2023 10-Q 2024-10-30
2022 -$89.5M -$45.2M -102% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$44.3M -$74.7M -246% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $30.4M +$31.3M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$914K +$32.8M +97.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$33.7M +$5.66M +14.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$39.3M +$76M +65.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$115M -$11.3M -10.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$104M -$23.8M -29.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 -$80.2M -$15.7M -24.4% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 -$64.5M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.